{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:59:47Z","timestamp":1781643587584,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["OBES SURG"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>The impact of chronic anticoagulation therapy (CAT) on sleeve gastrectomy (SG) conversions remains unclear. This study compared outcomes between patients with and without CAT undergoing SG conversions using the MBSAQIP database.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A retrospective analysis of the MBSAQIP database (2020\u20132022) included patients undergoing conversion from SG to Roux-en-Y gastric bypass (RYGB), single anastomosis duodeno-ileal bypass (SADI), or biliopancreatic diversion with duodenal switch (BPD-DS). Primary outcomes were 30-day serious complications. Secondary outcomes included specific complications, length of stay, and operative time. Multivariable logistic regression assessed whether CAT independently predicted outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Of 30,664 patients, 935 (3.05%) were on CAT. CAT patients were older (52.08 vs 45.73 years), had higher BMI (42.34 vs 40.33 kg\/m\u00b2), and higher rates of diabetes (24.71% vs 11.55%) and hypertension (82.21% vs71.32%) (all p&lt;0.001). Primary conversion indications were reflux disease(51.45%), weight recurrence (26.40%) and insufficient weight loss (14.86%).CAT patients had higher rates of serious complications (14.12% vs 6.42%),readmission (13.80% vs 6.88%), reoperation (4.92% vs 2.77%), and bleeding(4.81% vs 1.68%), with longer operative times (158.63 vs 144.01 minutes)and hospital stays (2.27 vs 1.68 days) (all p&lt;0.001). On multivariable analysis, CAT was not independently associated with serious complications(OR 1.06, 95%CI 0.61-1.85, p=0.824).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Patients on CAT undergoing SG conversions experience higher complication rates and longer hospital stays; However, anticoagulation therapy is not independently associated with increased serious complication safter adjusting for obesity-related conditions, highlighting the importance of comprehensive risk assessment and optimization of underlying medical conditions in all high-risk patients undergoing conversion bariatric surgery.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11695-026-08635-z","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T09:29:53Z","timestamp":1774430993000},"page":"2404-2413","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Adverse Outcomes in Patients on Chronic Anticoagulation Therapy Undergoing Sleeve Gastrectomy Conversions: Analysis of 30,664 Patients from the MBSAQIP Database"],"prefix":"10.1007","volume":"36","author":[{"given":"Juan S.","family":"Barajas-Gamboa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Restrepo-Rodas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"Mocanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lissa V.","family":"Wills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas H.","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pattharasai","family":"Kachornvitaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Romero-Velez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinlei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew T.","family":"Strong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvador","family":"Navarrete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricard","family":"Corcelles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A Daniel","family":"Guerron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Kroh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry T.","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"key":"8635_CR1","unstructured":"IFSO Global Registry Committee. Global Registry Report. International Federation for the Surgery of Obesity and Metabolic Disorders; 2024."},{"issue":"5","key":"8635_CR2","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1007\/s11695-023-06546-x","volume":"33","author":"JT Dang","year":"2023","unstructured":"Dang JT, Vaughan T, Mocanu V, Mubashir H, Barajas-Gamboa JS, Codina RC, Rodriguez J, Karmali S, Kroh M. Conversion of Sleeve Gastrectomy to Roux-en-Y Gastric Bypass: Indications, Prevalence, and Safety. Obes Surg. 2023;33(5):1486\u201393.","journal-title":"Obes Surg"},{"issue":"10","key":"8635_CR3","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.1007\/s11695-022-06229-z","volume":"32","author":"C Vanetta","year":"2022","unstructured":"Vanetta C, Dreifuss NH, Schlottmann F, Baz C, Masrur MA. Bariatric Surgery Conversions in MBSAQIP Centers: Current Indications and Outcomes. Obes Surg. 2022;32(10):3248\u201356.","journal-title":"Obes Surg"},{"issue":"10","key":"8635_CR4","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1007\/s11695-013-0972-5","volume":"23","author":"P Bechtel","year":"2013","unstructured":"Bechtel P, Boorse R, Rovito P, Harrison TD, Hong J. Warfarin Users Prone to Coagulopathy in First 30 Days After Hospital Discharge from Gastric Bypass. Obes Surg. 2013;23(10):1515\u20139.","journal-title":"Obes Surg"},{"issue":"12","key":"8635_CR5","doi-asserted-by":"publisher","first-page":"4007","DOI":"10.1007\/s11695-023-06910-x","volume":"33","author":"K Abi Mosleh","year":"2023","unstructured":"Abi Mosleh K, Belluzzi A, Salame M, Kendrick ML, Abu Dayyeh BK, McKenzie TJ, Ghanem OM. Long-Term Outcomes of Bariatric Surgery in Patients on Chronic Anticoagulation. Obes Surg. 2023;33(12):4007\u201316.","journal-title":"Obes Surg"},{"issue":"2","key":"8635_CR6","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s11695-007-9290-0","volume":"18","author":"R Mourelo","year":"2008","unstructured":"Mourelo R, Kaidar-Person O, Fajnwaks P, Roa PE, Pinto D, Szomstein S, Rosenthal RJ. Hemorrhagic and Thromboembolic Complications after Bariatric Surgery in Patients Receiving Chronic Anticoagulation Therapy. Obes Surg. 2008;18(2):167\u201370.","journal-title":"Obes Surg"},{"issue":"7","key":"8635_CR7","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1007\/s11695-018-3120-4","volume":"28","author":"G Sharma","year":"2018","unstructured":"Sharma G, Hanipah ZN, Aminian A, Punchai S, Bucak E, Schauer PR, Brethauer SA. Bariatric Surgery in Patients on Chronic Anticoagulation Therapy. Obes Surg. 2018;28(7):2225\u201332.","journal-title":"Obes Surg"},{"issue":"11","key":"8635_CR8","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1002\/phar.1307","volume":"33","author":"AN Irwin","year":"2013","unstructured":"Irwin AN, McCool KH, Delate T, Witt DM. Assessment of Warfarin Dosing Requirements After Bariatric Surgery in Patients Requiring Long-Term Warfarin Therapy. Pharmacotherapy. 2013;33(11):1175\u201383.","journal-title":"Pharmacotherapy"},{"issue":"5","key":"8635_CR9","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.amjmed.2016.12.033","volume":"130","author":"KA Martin","year":"2017","unstructured":"Martin KA, Lee CR, Farrell TM, Moll S. Oral Anticoagulant Use After Bariatric Surgery: A Literature Review and Clinical Guidance. Am J Med. 2017;130(5):517\u201324.","journal-title":"Am J Med"},{"key":"8635_CR10","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.thromres.2017.11.006","volume":"163","author":"A Rottenstreich","year":"2018","unstructured":"Rottenstreich A, Barkai A, Arad A, Raccah BH, Kalish Y. The Effect of Bariatric Surgery on Direct-Acting Oral Anticoagulant Drug Levels. Thromb Res. 2018;163:190\u20135.","journal-title":"Thromb Res"},{"issue":"7","key":"8635_CR11","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1111\/bcp.13243","volume":"83","author":"D Kr\u00f6ll","year":"2017","unstructured":"Kr\u00f6ll D, Stirnimann G, Vogt A, Lai DLL, Borb\u00e9ly YM, Altmeier J, Sch\u00e4delin S, Candinas D, Alberio L, Nett PC. Pharmacokinetics and Pharmacodynamics of Single Doses of Rivaroxaban in Obese Patients Prior to and After Bariatric Surgery. Br J Clin Pharmacol. 2017;83(7):1466\u201375.","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"8635_CR12","doi-asserted-by":"publisher","first-page":"424","DOI":"10.3390\/jcm14020424","volume":"14","author":"S Fares","year":"2025","unstructured":"Fares S, Barajas-Gamboa JS, Zhan K, Mocanu V, Dang JT, Birch DW, Switzer NJ, Karmali S. Perioperative Outcomes in Patients with and Without Chronic Preoperative Therapeutic Anticoagulation Undergoing Metabolic Surgery at an Academic Medical Center. J Clin Med. 2025;14(2):424.","journal-title":"J Clin Med"},{"issue":"9","key":"8635_CR13","doi-asserted-by":"publisher","first-page":"4177","DOI":"10.1007\/s00464-019-07191-1","volume":"34","author":"MS Altieri","year":"2020","unstructured":"Altieri MS, Yang J, Zhu C, Spaniolas K, Talamini MA, Pryor AD. Preoperative Anticoagulation in Patients Undergoing Bariatric Surgery is Associated with Worse Outcomes. Surg Endosc. 2020;34(9):4177\u201384.","journal-title":"Surg Endosc"},{"issue":"3","key":"8635_CR14","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1503\/cjs.006116","volume":"60","author":"C Fulton","year":"2017","unstructured":"Fulton C, Sheppard C, Birch D, Karmali S, de Gara C. A Comparison of Revisional and Primary Bariatric Surgery. Can J Surg. 2017;60(3):205\u201311.","journal-title":"Can J Surg"},{"issue":"6","key":"8635_CR15","first-page":"2062","volume":"34","author":"JS Barajas-Gamboa","year":"2024","unstructured":"Barajas-Gamboa JS, Serra FE, Romero-Velez G, et al. Bariatric Surgical Outcomes in the Elderly: A Comparison Study Between Primary and Revisional Procedures in the United Arab Emirates. Obes Surg. 2024;34(6):2062\u201373.","journal-title":"Obes Surg"},{"issue":"12","key":"8635_CR16","doi-asserted-by":"publisher","first-page":"6466","DOI":"10.1007\/s00464-020-08137-8","volume":"35","author":"P Hauters","year":"2021","unstructured":"Hauters P, Dubart JW, Desmet J, Degolla R, Roumain M, Malvaux P. Ten-Year Outcomes After Primary Vertical Sleeve Gastrectomy for Morbid Obesity: A Monocentric Cohort Study. Surg Endosc. 2021;35(12):6466\u201371.","journal-title":"Surg Endosc"},{"issue":"7","key":"8635_CR17","doi-asserted-by":"publisher","first-page":"5516","DOI":"10.1007\/s00464-022-09654-4","volume":"37","author":"J Jen","year":"2023","unstructured":"Jen J, Phan H, Johnson B, Blyn C, Lavrich J, Mallem K, Pai PK, Krecioch P. Comparing Weight Loss Outcomes After Conversion to Roux-en-Y Gastric Bypass Versus Duodenal Switch from Sleeve Gastrectomy in a Community Hospital. Surg Endosc. 2023;37(7):5516\u201325.","journal-title":"Surg Endosc"},{"issue":"11","key":"8635_CR18","doi-asserted-by":"publisher","first-page":"4708","DOI":"10.1007\/s11695-021-05609-1","volume":"31","author":"PJ Dijkhorst","year":"2021","unstructured":"Dijkhorst PJ, Al Nawas M, Heusschen L, Hazebroek EJ, Swank DJ, Wiezer RMJ, Aarts EO. Single Anastomosis Duodenoileal Bypass or Roux-en-Y Gastric Bypass After Failed Sleeve Gastrectomy: Medium-Term Outcomes. Obes Surg. 2021;31(11):4708\u201316.","journal-title":"Obes Surg"},{"issue":"12","key":"8635_CR19","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/j.amjmed.2021.07.017","volume":"134","author":"MF Nasser","year":"2021","unstructured":"Nasser MF, Jabri A, Gandhi S, Rader F. Oral Anticoagulant Use in Morbid Obesity and Post Bariatric Surgery: A Review. Am J Med. 2021;134(12):1465\u201375.","journal-title":"Am J Med"},{"key":"8635_CR20","unstructured":"Rushmeyer M, Weighing, the Recommendations for Oral Anticoagulant Use Following Bariatric Surgery. In on. Pharm Times [Internet]. 2024 Mar 6 [cited 2025 Mar 6]. Available from: https:\/\/www.pharmacytimes.com\/view\/weighing-in-on-the-recommendations-for-oral-anticoagulant-use-following-bariatric-surgery"},{"issue":"4","key":"8635_CR21","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/j.1365-2796.2007.01913.x","volume":"263","author":"S Schulman","year":"2008","unstructured":"Schulman S, El Bouazzaoui B, Eikelboom JW, Zondag M. Clinical Factors Influencing the Sensitivity to Warfarin When Restarted After Surgery. J Intern Med. 2008;263(4):412\u20139.","journal-title":"J Intern Med"},{"issue":"11","key":"8635_CR22","doi-asserted-by":"publisher","first-page":"3432","DOI":"10.1007\/s11695-019-04064-3","volume":"29","author":"A Modasi","year":"2019","unstructured":"Modasi A, Dang JT, Afraz S, Hefler J, Switzer N, Birch DW, Karmali S. Bariatric Surgery Outcomes in Patients on Preoperative Therapeutic Anticoagulation: An Analysis of the 2015 to 2017 MBSAQIP. Obes Surg. 2019;29(11):3432\u201342.","journal-title":"Obes Surg"},{"issue":"9","key":"8635_CR23","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1007\/s11695-015-1590-1","volume":"25","author":"O Gerin","year":"2015","unstructured":"Gerin O, Rebibo L, Dhahri A, Regimbeau JM. The Safety of Laparoscopic Sleeve Gastrectomy in Patients Receiving Chronic Anticoagulation Therapy: A Case-Matched Study. Obes Surg. 2015;25(9):1686\u201392.","journal-title":"Obes Surg"},{"issue":"6","key":"8635_CR24","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1381\/096089296765556377","volume":"6","author":"BM Owens","year":"1996","unstructured":"Owens BM, Owens ML, Hill CW. Effect of Revisional Bariatric Surgery on Weight Loss and Frequency of Complications. Obes Surg. 1996;6(6):479\u201384.","journal-title":"Obes Surg"},{"issue":"6","key":"8635_CR25","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1007\/s00464-014-3848-4","volume":"29","author":"L Zhang","year":"2015","unstructured":"Zhang L, Tan WH, Chang R, Eagon JC. Perioperative Risk and Complications of Revisional Bariatric Surgery Compared to Primary Roux-en-Y Gastric Bypass. Surg Endosc. 2015;29(6):1316\u201320.","journal-title":"Surg Endosc"},{"issue":"11","key":"8635_CR26","doi-asserted-by":"publisher","first-page":"8481","DOI":"10.1007\/s00464-022-09146-5","volume":"36","author":"R Sebastian","year":"2022","unstructured":"Sebastian R, Ghanem OM, Cornejo J, Ruttger T, Perales-Villarroel JP, Adrales G, Li C. Is Staple Line Oversewing in Patients on Chronic Anticoagulation During Laparoscopic Sleeve Gastrectomy Necessary? Propensity Score Matching Analysis Using the 2015\u20132018 MBSAQIP. Surg Endosc. 2022;36(11):8481\u20139.","journal-title":"Surg Endosc"},{"issue":"3","key":"8635_CR27","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00464-018-6348-0","volume":"33","author":"JT Dang","year":"2019","unstructured":"Dang JT, Switzer N, Delisle M, Laffin M, Gill R, Birch DW, Karmali S. Predicting Venous Thromboembolism Following Laparoscopic Bariatric Surgery: Development of the BariClot Tool Using the MBSAQIP Database. Surg Endosc. 2019;33(3):821\u201331.","journal-title":"Surg Endosc"},{"issue":"1","key":"8635_CR28","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13017-021-00349-0","volume":"16","author":"B De Simone","year":"2021","unstructured":"De Simone B, Chouillard E, Sartelli M, et al. The Management of Surgical Patients in the Emergency Setting During COVID-19 Pandemic: The WSES Position Paper. World J Emerg Surg. 2021;16(1):14.","journal-title":"World J Emerg Surg"},{"issue":"10","key":"8635_CR29","first-page":"2637","volume":"8","author":"DM Siegal","year":"2024","unstructured":"Siegal DM, Tseng EK, Sch\u00fcnemann HJ, et al. ASH Living Guidelines on Use of Anticoagulation for Thromboprophylaxis in Patients with COVID-19: Executive Summary. Blood Adv. 2024;8(10):2637\u201357.","journal-title":"Blood Adv"},{"issue":"10","key":"8635_CR30","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1111\/jth.15808","volume":"20","author":"S Schulman","year":"2022","unstructured":"Schulman S, Sholzberg M, Spyropoulos AC, et al. ISTH Guidelines for Antithrombotic Treatment in COVID-19. J Thromb Haemost. 2022;20(10):2214\u201325.","journal-title":"J Thromb Haemost"}],"container-title":["Obesity Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-026-08635-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11695-026-08635-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-026-08635-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:50:49Z","timestamp":1781643049000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11695-026-08635-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,25]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["8635"],"URL":"https:\/\/doi.org\/10.1007\/s11695-026-08635-z","relation":{},"ISSN":["0960-8923","1708-0428"],"issn-type":[{"value":"0960-8923","type":"print"},{"value":"1708-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,25]]},"assertion":[{"value":"29 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Matthew Kroh serves as Chief Medical Officer for Core Surgical Innovation, Medtronic. This position is unrelated to the current study, and there are no financial or commercial associations between this research and Medtronic or any of its products. All other authors declare no competing financial or non-financial interests relevant to this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"Preliminary results from this study were presented as a poster at SAGES 2025 (Long Beach, California); however, this manuscript represents the complete analysis and has not been published elsewhere.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study was exempt from institutional review board approval as the MBSAQIP Participant User File (PUF) contains only de-identified patient data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was waived for this retrospective study in accordance with institutional and national research ethics guidelines.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of Informed Consent"}}]}}